Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Sutro Biopharma Total Assets 2017-2019 | STRO

Sutro Biopharma total assets from 2017 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Sutro Biopharma Annual Total Assets
(Millions of US $)
2018 $223
2017 $41
2016 $69
Sutro Biopharma Quarterly Total Assets
(Millions of US $)
Q3 2019 $172
Q2 2019 $189
Q1 2019 $202
Q4 2018 $223
Q3 2018 $145
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q4 2016 $69
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.263B $0.038B
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.503B 15.03
CSL (CSLLY) Australia $103.320B 0.00
Gilead Sciences (GILD) United States $85.208B 10.97
Vertex Pharmaceuticals (VRTX) United States $64.242B 58.30
Biogen (BIIB) United States $59.363B 10.14
Illumina (ILMN) United States $44.570B 46.08
Regeneron Pharmaceuticals (REGN) United States $44.096B 18.68
Alexion Pharmaceuticals (ALXN) United States $22.851B 10.63
Seattle Genetics (SGEN) United States $20.652B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.867B 38.33
BioMarin Pharmaceutical (BMRN) United States $16.143B 0.00
Genmab (GNMSF) Denmark $14.941B 48.06
Galapagos (GLPG) Belgium $14.619B 37.67
Alnylam Pharmaceuticals (ALNY) United States $14.523B 0.00
Exact Sciences (EXAS) United States $13.310B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.577B 0.00
Sarepta Therapeutics (SRPT) United States $9.087B 0.00
QIAGEN (QGEN) Netherlands $8.382B 25.81
Guardant Health (GH) United States $8.138B 0.00
Bio-Techne Corp (TECH) United States $8.079B 55.29
BioNTech SE (BNTX) Germany $7.297B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.061B 0.00
Ascendis Pharma (ASND) Denmark $6.883B 0.00
Reata Pharmaceuticals (RETA) United States $6.782B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.754B 17.17
Exelixis (EXEL) United States $6.624B 18.63
Amarin (AMRN) Ireland $6.466B 0.00
Moderna (MRNA) United States $6.367B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.169B 0.00
Repligen (RGEN) United States $5.682B 102.96
Acceleron Pharma (XLRN) United States $5.013B 0.00
China Biologic Products (CBPO) China $4.590B 25.86
Bluebird Bio (BLUE) United States $4.474B 0.00
Adaptive Biotechnologies (ADPT) United States $4.168B 0.00
MorphoSys AG (MOR) Germany $3.939B 0.00
Mirati Therapeutics (MRTX) United States $3.845B 0.00
Zai Lab (ZLAB) China $3.655B 0.00
NeoGenomics (NEO) United States $3.598B 191.47
Ultragenyx Pharmaceutical (RARE) United States $3.563B 0.00
Blueprint Medicines (BPMC) United States $3.561B 0.00
Immunomedics (IMMU) United States $3.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.536B 59.91
Momenta Pharmaceuticals (MNTA) United States $3.346B 0.00
Emergent Biosolutions (EBS) United States $3.334B 33.12
MyoKardia (MYOK) United States $3.176B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.150B 0.00
Genmab (GMAB) Denmark $3.123B 6.43
Halozyme Therapeutics (HALO) United States $3.102B 0.00
Alkermes (ALKS) Ireland $2.946B 233.38
UniQure (QURE) Netherlands $2.830B 0.00
Insmed (INSM) United States $2.773B 0.00
Amicus Therapeutics (FOLD) United States $2.755B 0.00
Arena Pharmaceuticals (ARNA) United States $2.703B 6.29
Denali Therapeutics (DNLI) United States $2.516B 0.00
Principia Biopharma (PRNB) United States $2.313B 0.00
Epizyme (EPZM) United States $2.293B 0.00
Fate Therapeutics (FATE) United States $2.238B 0.00
RA PHARMCTL INC (RARX) United States $2.206B 0.00
Alector (ALEC) United States $2.058B 0.00
REGENXBIO (RGNX) United States $1.988B 0.00
Zymeworks (ZYME) Canada $1.851B 0.00
Ligand Pharmaceuticals (LGND) United States $1.781B 51.99
Akcea Therapeutics (AKCA) United States $1.732B 0.00
Arvinas (ARVN) United States $1.716B 0.00
Coherus BioSciences (CHRS) United States $1.578B 0.00
Zealand Pharma (ZEAL) Denmark $1.517B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.503B 0.00
Myriad Genetics (MYGN) United States $1.490B 26.30
Dicerna Pharmaceuticals (DRNA) United States $1.391B 0.00
Editas Medicine (EDIT) United States $1.362B 0.00
Intra-Cellular Therapies (ITCI) United States $1.331B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.207B 0.00
Athenex (ATNX) United States $1.207B 0.00
Revance Therapeutics (RVNC) United States $1.203B 0.00
Adverum Biotechnologies (ADVM) United States $1.046B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Twist Bioscience (TWST) United States $1.008B 0.00
PHARMA MAR SA (PHMMF) Spain $1.005B 0.00
Mesoblast (MESO) Australia $0.931B 0.00
Cytokineticsorporated (CYTK) United States $0.929B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
DBV Technologies S.A (DBVT) France $0.883B 0.00
Sangamo Therapeutics (SGMO) United States $0.866B 0.00
Vericel (VCEL) United States $0.849B 316.67
Codexis (CDXS) United States $0.818B 0.00
Heska (HSKA) United States $0.808B 206.36
Cellectis S.A (CLLS) France $0.789B 0.00
ANI Pharmaceuticals (ANIP) United States $0.759B 12.95
Intrexon (PGEN) United States $0.747B 0.00
Retrophin (RTRX) United States $0.724B 0.00
Arcus Biosciences (RCUS) United States $0.722B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.717B 6.03
Cara Therapeutics (CARA) United States $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.685B 0.00
GENFIT S.A (GNFT) France $0.681B 0.00
Kadmon Holdings (KDMN) United States $0.667B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.625B 0.00
Anika Therapeutics (ANIK) United States $0.607B 19.71
Agenus (AGEN) United States $0.603B 0.00
NantKwest (NK) United States $0.597B 0.00
Cel-Sci (CVM) United States $0.586B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.585B 0.00
AC Immune SA (ACIU) Switzerland $0.578B 13.38
Clovis Oncology (CLVS) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Bellus Health (BLU) Canada $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.543B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.521B 0.00
Compugen (CGEN) Israel $0.502B 0.00
BioDelivery Sciences (BDSI) United States $0.479B 0.00
Prothena (PRTA) Ireland $0.478B 0.00
Cue Biopharma (CUE) United States $0.474B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.455B 0.00
Sorrento Therapeutics (SRNE) United States $0.438B 0.00
Mersana Therapeutics (MRSN) United States $0.437B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.425B 0.00
AnaptysBio (ANAB) United States $0.421B 0.00
Precision BioSciences (DTIL) United States $0.418B 0.00
Dynavax Technologies (DVAX) United States $0.417B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.417B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.415B 0.00
PDL BioPharma (PDLI) United States $0.412B 10.31
Avid Bioservices (CDMO) United States $0.405B 0.00
Pfenex (PFNX) United States $0.392B 0.00
Inovio Pharmaceuticals (INO) United States $0.386B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Gritstone Oncology (GRTS) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.363B 0.00
Albireo Pharma (ALBO) United States $0.330B 0.00
CytomX Therapeutics (CTMX) United States $0.329B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.313B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.310B 2.15
Syros Pharmaceuticals (SYRS) United States $0.304B 0.00
OSMOTICA PHARM (OSMT) United States $0.301B 0.00
WAVE Life Sciences (WVE) Singapore $0.297B 0.00
MannKind (MNKD) United States $0.295B 0.00
Starpharma Holdings (SPHRY) Australia $0.294B 0.00
Aduro Biotech (ADRO) United States $0.290B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.283B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.280B 0.00
Kamada (KMDA) Israel $0.272B 11.31
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
VBI Vaccines (VBIV) United States $0.267B 0.00
IVERIC Bio (ISEE) United States $0.267B 0.00
Geron (GERN) United States $0.260B 0.00
Novavax (NVAX) United States $0.255B 0.00
Seres Therapeutics (MCRB) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.243B 0.00
ChromaDex (CDXC) United States $0.241B 0.00
Protagonist Therapeutics (PTGX) United States $0.240B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.230B 0.00
Alcobra (ARCT) United States $0.225B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.225B 11.54
Nymox Pharmaceutical (NYMX) Canada $0.219B 0.00
Theratechnologies (THTX) Canada $0.211B 0.00
Prometic Life Sciences (LMNL) Canada $0.211B 0.00
Cerecor (CERC) United States $0.211B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.207B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.206B 0.00
TELA Bio (TELA) United States $0.205B 0.00
Arbutus Biopharma (ABUS) Canada $0.203B 0.00
Athersys (ATHX) United States $0.197B 0.00
Fortress Biotech (FBIO) United States $0.194B 0.00
Five Prime Therapeutics (FPRX) United States $0.190B 0.00
Strongbridge Biopharma (SBBP) United States $0.190B 5.09
Exicure (XCUR) United States $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.176B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
CorMedix Inc (CRMD) United States $0.166B 0.00
Aptinyx (APTX) United States $0.163B 0.00
Verastem (VSTM) United States $0.158B 0.00
Dyadic (DYAI) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.150B 0.00
Celyad SA (CYAD) Belgium $0.150B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
PHASEBIO PHARMA (PHAS) United States $0.143B 0.00
Antibe Therapeutics (ATBPF) Canada $0.139B 0.00
Menlo Therapeutics (MNLO) United States $0.135B 0.00
Palatin Technologies (PTN) United States $0.134B 3.66
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
ARAVIVE, INC (ARAV) United States $0.134B 0.00
Arsanis (XFOR) United States $0.130B 0.00
OvaScience (MLND) United States $0.124B 0.00
Clearside Biomedical (CLSD) United States $0.123B 0.00
Northwest Biotherapeutics (NWBO) United States $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Prima BioMed (IMMP) Australia $0.112B 0.00
Enzo Biochem (ENZ) United States $0.108B 0.00
Happiness Biotech Group (HAPP) China $0.106B 0.00
Applied Genetic Technologies (AGTC) United States $0.101B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.088B 0.00
Proteostasis Therapeutics (PTI) United States $0.088B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.085B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
Emmaus Life Sciences (EMMA) United States $0.083B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.080B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
Orgenesis (ORGS) United States $0.078B 5.04
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Trevena (TRVN) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Soligenix (SNGX) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
Advaxis (ADXS) United States $0.064B 0.00
DiaMedica Therapeutics (DMAC) United States $0.064B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.058B 0.00
Bioxytran (BIXT) United States $0.058B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
Stellar Biotechnologies (EDSA) Canada $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Celsion (CLSN) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Signal Genetics (MGEN) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
TOCAGEN INC (TOCA) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00